Enjoy complimentary customisation on priority with our Enterprise License!
The global fertility services market size is estimated to grow by USD 8.17 billion at a CAGR of 7.18% between 2023 and 2028. The rising prevalence of late parenthood, driven by social and economic factors, is increasing the demand for fertility treatments and services. The increase in fertility tourism, where individuals travel to other countries for fertility treatments, is expanding the market globally. Additionally, the rising number of fertility clinics, both locally and internationally, is providing more access to treatments and services, further driving market growth. Furthermore, advancements in treatments and technologies are increasing success rates, making fertility treatments more appealing to a wider audience. The growing acceptance and awareness of these issues are also reducing stigma, and encouraging more people to seek treatments.
To learn more about this report, Request Free Sample
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Anecova SA, Apollo Hospitals Enterprise Ltd, CARE Fertility Group Ltd., Carolinas Fertility Institute, Cryolab Ltd., Genea Ltd., Instituto Bernabeu SL, Instituto Valenciano de Infertilidad, Kids Clinic India Pvt. Ltd., Lucile Packard Childrens Hospital, Medicover AB, Merck KGaA, Monash IVF Group Ltd., Nova IVF Fertility Private Ltd, The Cooper Companies Inc., The Johns Hopkins Health System Corp., University of Pennsylvania Health System, Virtus Health, Vitrolife AB, and Xytex Corp.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market share growth by the treatment services segment will be significant during the forecast period. The treatment services segment is the highest revenue contributor to the market primarily due to the high cost of services and the prevalence of diseases such as diabetes and obesity in both men and women that adversely impact their fertility and impair the functions of their reproductive organs.
Get a glance at the market contribution of various segments Download PDF Sample
The treatment services segment was valued at USD 6.33 billion in 2018. There is also an increase in awareness among women in semi-urban areas, predominantly in developed countries, thereby leading to the gradual adoption of these treatments. However, the affordability of the procedure is a major impediment in rural areas. Thus, an increase in such initiatives, convenience, improving the education system, and growing disposable incomes are likely to drive the market for treatment services and, in turn, support the growth of the market.
For more insights about the market share of various regions Download PDF Sample
North America is estimated to contribute 32% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. The market share of North America is high due to the presence of a well-established healthcare system that provides high-quality services, primarily through clinics and hospitals. Rising investment in the healthcare sector in the US also contributes to the high market share. The US is the dominating country in the region and acts as the major revenue generator, followed by Canada. Huge investment in the pharmaceutical industry and the presence of many pharmaceutical giants are major factors backing up the dominance of the US in the region and even globally.
The market encompasses a broad spectrum of healthcare facilities specializing in in vitro fertilization (IVF) and other Assisted Reproductive Technology (ART) services. These clinics address various factors influencing infertility, such as sperm morphology, sperm motility, and sperm count in males, and conditions like Polycystic Ovary Syndrome (PCOS), Endometrial tuberculosis, and Sexually Transmitted Diseases (STDs) in females. Services cater to both male infertility (including issues like low sperm count and hormonal imbalance) and female infertility (related to gland function). The market also supports procedures like surrogacy and non-donor IVF, offering hope to couples facing challenges in conception. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The rising prevalence of late parenthood is the key factor driving the market growth. The increasing age of parenthood is a significant factor contributing to issues, particularly impacting European countries and some Asian nations like Japan. This trend towards later motherhood goes against the natural fertility window for women, which is typically highest in their mid-20s, starting to decline in their early 30s and decreasing further after 35 years.
Moreover, advanced age reduces the likelihood of pregnancy and increases the risk of complications such as gestational diabetes, high blood pressure, and larger babies. Factors such as alcohol and drug use, stress levels, smoking, obesity, and environmental factors can also affect fertility and pregnancy outcomes. Consequently, the rising prevalence of delayed parenthood is expected to increase the demand for these services such as various treatment options (ICSI, zygote intrafallopian transfer, gamete intrafallopian transfer, IVF), as well as testing and storage services, benefiting the market in the market growth analysis period.
The rising number of sperm donors at sperm banks is the primary trend in the market growth. There has been a rise in the number of sperm donors in the recent past because of the rise in the number of donors for money. The amount paid to donors is attracting more donors each year. The sperm specimen given by an anonymous donor is used for insemination purposes and injected into the uterus using a syringe to achieve pregnancy. This process can be conducted at hospitals, clinics, and also at home with varying degrees of success.
Further, the rising number of donors at sperm banks gives the service providers access to a larger pool of semen samples used for treatment. As these treatments usually require more than one sample per patient, it provides a larger scope for revenue generation to service providers in the market. Thus, the rise in the number of donors will lead to an increase in the use of these services and several treatments such as artificial insemination, gamete intrafallopian transfer, and IVF, thus boosting their sales in the future.
The high complication rate in fertility services is a major challenge to market growth. The treatments can cause various complications, including multiple pregnancies, ovarian hyperstimulation syndrome, internal bleeding or infection, premature delivery, the birth of low-weight babies, and congenital defects. Complications related to male fertility services are rare but can occur in people undergoing surgeries. These complications include infections, bruising, bleeding, and limited efficacy of services.
Further, allergic reactions to anesthesia are also potential side effects of these treatments. Antibiotics and other medications can cause diarrhea in some people. Gonadotropins may cause hot flushes, breast tenderness, swelling, abdominal pain, bloating, and menopause-type symptoms. These complications of these treatment services and medications limit their use and can lead away from the prospective client base due to the fear of side effects or adverse outcomes of procedures. Such factors will hinder market growth during the market growth and forecasting period.
The market forecast report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market forecasting and growth strategies.
Customer Landscape
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion " for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
You may also be interested in:
Fertility Testing Devices Market - Fertility Testing Devices Market by Product and Geography - Forecast and Analysis
Ovulation Test Market - Ovulation Test Market by Type and Geography - Forecast and Analysis
Fertility Supplements Market - Fertility Supplements Market by End-user and Geography - Forecast and Analysis
The market is a diverse sector addressing infertility due to medical conditions like Polycystic Ovarian Syndrome (PCOS) through specialized fertility clinics and infertility treatment hospitals. Advancements such as Artificial Intelligence (AI) and robotics aid in procedures like In-Vitro Fertilization (IVF), Hysteroscopy, IUI, and Laparoscopy, enhancing Assisted Reproductive Technologies (ARTs). Tailored human-centered care (HCC) at centers like Oma Fertility supports infertile couples, single parents, and the LGBT community in family planning. Lifestyle changes addressing factors like alcohol use, sedentary habits, and medical ailments are pivotal. Services include egg-freezing and oocyte cryopreservation, catering to those prioritizing career and academic ambitions. Marketing via televisions, online portals, and advertising educates on causes and treatments, fostering financial stability amid delayed pregnancies and childcare services needs.
Market Scope |
|
Report Coverage |
Details |
Page number |
179 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.18% |
Market growth 2024-2028 |
USD 8.17 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
6.57 |
Regional analysis |
North America, Europe, APAC, Middle East and Africa, and South America |
Performing market contribution |
North America at 32% |
Key countries |
US, UK, China, Germany, and India |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Anecova SA, Apollo Hospitals Enterprise Ltd, CARE Fertility Group Ltd., Carolinas Fertility Institute, Cryolab Ltd., Genea Ltd., Instituto Bernabeu SL, Instituto Valenciano de Infertilidad, Kids Clinic India Pvt. Ltd., Lucile Packard Childrens Hospital, Medicover AB, Merck KGaA, Monash IVF Group Ltd., Nova IVF Fertility Private Ltd, The Cooper Companies Inc., The Johns Hopkins Health System Corp., University of Pennsylvania Health System, Virtus Health, Vitrolife AB, and Xytex Corp. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Service
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.